Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Neutrophil Extracellular Traps Kill Bacteria

Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268

Age-related clonal hematopoiesis associated with adverse outcomes

Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531

Extracellular DNA traps promote thrombosis

Fuchs, T. A., Brill, A. G., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D., Wrobleski, S. K., Wakefield, T. W., Hartwig, J. H., & Wagner, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005743107 · Cited by 2,591

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M., Miller, C., Silver, R. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110557 · Cited by 2,103

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Klampfl, T., Gisslinger, H., Harutyunyan, A. S., Nivarthi, H., Rumi, E., Milosevic, J. D., Them, N. C. C., Berg, T., Gisslinger, B., Pietra, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311347 · Cited by 2,003

Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation

Wang, Y., Li, M., Stadler, S. C., Correll, S., Li, P., Wang, D., Hayama, R., Leonelli, L., Han, H., Grigoryev, S. A., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200806072 · Cited by 1,579

PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps

Li, P., Li, M., Lindberg, M. R., Kennett, M. J., Xiong, N., & Wang, Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100239 · Cited by 1,495

Diabetes primes neutrophils to undergo NETosis, which impairs wound healing

Wong, S. L., Demers, M., Martinod, K., Gallant, M., Wang, Y., Goldfine, A. B., Kahn, C. R., & Wagner, D. D. (2015) · Nature Medicine · doi:10.1038/nm.3887 · Cited by 1,264

Neutrophil extracellular traps promote deep vein thrombosis in mice

Brill, A. G., Fuchs, T. A., Savchenko, A. S., Thomas, G. M., Martinod, K., Meyer, S. F. D., Bhandari, A. A., & Wagner, D. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04544.x · Cited by 933

Targeting the JAK2V617F mutant hematopoietic microenvironment in myeloproliferative neoplasm

Yeware, A. M. (2026) · Frontiers in Hematology · doi:10.3389/frhem.2025.1694867 · Cited by 1

Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease

Migliozzi, L., Marassi, M., Albiero, M., & Fadini, G. P. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70137 · Cited by 1

Ageing Through the Looking‐Glass: The Different Flavours of Clonal Haematopoiesis

Singh, J., Curtis, D. J., Thảo, L. T. P., Wood, E. M., & McQuilten, Z. (2026) · Aging Cell · doi:10.1111/acel.70425 · Cited by 1

Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification

Szarpak, P. L., Jach, M. E., Skoczylas, M. M., Radej, S., & Pruc, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062750 · Cited by 1

Thrombotic and Bleeding Complications in Myeloproliferative Neoplasms: An Integrated Clinical Perspective

Cohen, O. Y., & Ellis, M. H. (2026) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2836-0670 · Cited by 1

Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms

Mergen, G., & Hasselbalch, H. C. (2026) · Frontiers in Hematology · doi:10.3389/frhem.2026.1749376 · Cited by 1

Telehealth-Delivered Dietary Counseling in Myeloproliferative Neoplasms: A Randomized Feasibility Study

Fleischman, A. G., Li, J., Tabban, A., Cai, S., & Odegaard, A. (2026) · Nutrients · doi:10.3390/nu18071158 · Cited by 1

Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia

Olcar, S., Elverdi, T., Bolayırlı, M., Eşkazan, A. E., Özmen, D., Çerme, M. D. Ö., Salihoğlu, A., Başlar, Z., & Ar, M. C. (2026) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296261462870 · Cited by 1

Is clonal haematopoiesis the missing link between lupus and cardiovascular disease?

Shamsi, A., Wincup, C., Pericleous, C., Tariq, F., Sadler, M., Quek, L. S., & Bromage, D. I. (2026) · Rheumatology · doi:10.1093/rheumatology/keag330 · Cited by 1

Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms

El‐Sehrawy, A. A. M. A., Al‐Khreisat, M. J., Kibriyeva, M., Dilbar, I., Axmedova, F., Mohammed, J. A., Mishra, S., & Tailor, N. K. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02247-8 · Cited by 1

Clonal haematopoiesis of indeterminate potential in cardiovascular medicine: is it time for selective testing?

Oren, O., & Libby, P. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag454 · Cited by 1

Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease: Gene-Specific Mechanisms and Therapeutic Implications

Zhang, X., Zhang, H., Fu, J., Feng, S., & Wang, Y. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s626604 · Cited by 1

Clonal hematopoiesis as a context-dependent modifier of organ-specific disease: Evidence, mechanisms, and translational boundaries

Tang, B., Kuai, Y., Ye, Z., Zhao, X., Fan, C., Huang, M., Luo, Y., & Li, C. (2026) · Cell investigation. · doi:10.1016/j.clnves.2026.100088 · Cited by 1

Neutrophils in cancer

Diehl, M. I., Basto, P. A., Abikenari, M. A., Linde, I. L., Okwan-Duodu, D. K., & Engleman, E. G. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00968-2 · Cited by 1

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis of Indeterminate Potential

Chiu, N., Oren, O., Small, A. M., Weeks, L. D., Marston, N., Honigberg, M. C., & Libby, P. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.3593 · Cited by 1

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Warzocha, K., Homenda, W., Pluta, A., Sacha, T., Cioch, M., Dudziński, M., Krochmalczyk, D., Góra‐Tybor, J., Seferyńska, I., Joks, M., et al. (2019) · Oncology in Clinical Practice · doi:10.5603/ocp.2019.0021 · Cited by 1

Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing—A prevalence study of patients in Mecklenburg-West Pomerania (2017–2021)

Henze, L., Grunwald, L., Felser, S., Witte, M. B., Große-Thie, C., Roolf, C., Escobar, H. M., & Junghanß, C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1344769 · Cited by 1

Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)–negative myeloproliferative neoplasms

Wen, S., Zhang, W., Fei, Y., Guan, K., Zhao, H., Peng, S., Ye, X., & Pan, Y. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.05.025 · Cited by 1

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health

Raddatz, M. A., Pershad, Y., Parker, A., & Bick, A. G. (2024) · Cardiology Clinics · doi:10.1016/j.ccl.2024.08.004 · Cited by 1

Trampas extracelulares de neutrófilos (NETs) y COVID-19: revisión de la literatura científica

Barragán, F. E. R., González, F. E. J., & Vélez-Páez, J. L. (2024) · Revista chilena de infectología · doi:10.4067/s0716-10182024000400135 · Cited by 1

Clonal haematopoiesis and ionizing radiation: risks for hematological malignancies and somatic diseases

Zherniakova, A., Крысюк, О. Б., & Kunevich, Y. O. (2024) · Extreme Medicine · doi:10.47183/mes.2024-26-4-5-12 · Cited by 1

Exploring the interplay between myeloproliferative disorders and atherosclerosis

Khan, M., Banerjee, S., Kumari, R., Chowdhury, S. R., Madkour, N., Ogieuhi, I. J., Agbo, C. E., Ajekiigbe, V. O., Ntukidem, O. L., Atunde, F. J., et al. (2025) · Discover Medicine · doi:10.1007/s44337-025-00278-w · Cited by 1

Clonal Hematopoiesis in Cardiogenic Shock

Collet, J., Rahoual, G., & Hulot, J. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.002 · Cited by 1

Idiopathic splanchnic vein thrombosis: is it really idiopathic?

Barosi, G. (2022) · Haematologica · doi:10.3324/haematol.2022.281998 · Cited by 1

The impact of thrombosis and bleeding among patients with Myeloproliferative Neoplasm: Systematic Review and Meta-AnalysisPreprint

Brhanie, T. W., Fava, C., & Jovanovski, A. (2020) · medRxiv · doi:10.1101/2020.08.27.20182535

Cerebrovascular risk factors are the predictive factor for ischemic cerebrovascular diseases in patients with Philadelphia chromosome (Ph)–negative myeloproliferative neoplasms: a case control studyPreprint

Wen, S., Zhang, W., Fei, Y., Guan, K., Zhao, H., Peng, S., Ye, X., Cao, F., Zhou, J., & Pan, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-209712/v1

Impacto del perfil mutacional sobre el riesgo trombótico en pacientes con cáncer

Páramo, J. A., Marcos‐Jubilar, M., & Lecumberri, R. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.04.005

Neutrophil Extracellular Traps Participate in the Development of Gastric Cancer Associated ThrombosisPreprint

Li, J., Zou, X., Yang, S., Jin, J., Zhu, L., Li, C., Yang, H., Zhang, A., & Chen, C. (2021) · Research Square · doi:10.21203/rs.3.rs-723574/v1

Precious Wetlands Rapidly Disappearing

Sato, H. (2006)

Faculty Opinions recommendation of Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

DeLeo, F. R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736190778.793580563

Faculty Opinions recommendation of Neutrophil accumulation and NET release contribute to thrombosis in HIT.

DeLeo, F. R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734070154.793580566

The Role of the NETosis Phenomena as a Function of Neutrophils in the Pathogenesis of Infection and Cancer

Glukhareva, A. E., Afonin, G. V., Aa, M., Grivtsova, L. Y., Kolobaev, I. V., Ivanov, S. A., & Kaprin, A. D. (2022) · Austin Journal of Infectious Diseases · doi:10.26420/austinjinfectdis.2022.1074

MECHANISMS OF THE OCCURRENCE OF THROMBOTIC PHENOMENA IN MYELOPROLIFERATIVE NEOPLASIA

Voroniak, M., Kokoruz, M. V., Hudzij, S., & Novak, V. L. (2023) · HEMATOLOGY AND BLOOD TRANSFUSION INTERDEPARTAMENTAL COLLECTION · doi:10.33741/0435-1991.42.21

Thrombosis and Myeloproliferative Neoplasms

Guy, A., & James, C. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_45

JAK Inhibitors for the Management of Myeloproliferative Neoplasms

Bose, P., & Verstovšek, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_43

The Role of Leukocytes in the Formation of Neutrophil Extracellular Traps and Thrombosis in Ph-Negative Myeloproliferative Neoplasms: A Literature Review

Bt, D. (2023) · Clinical oncohematology · doi:10.21320/2500-2139-2023-16-3-263-267

Polycythemia Vera

Boseand, P., & Verstovšek, S. (2023) · Wiley eBooks · doi:10.1002/9781119823193.ch21

Impact de l'inflammation sur les complications post-procédurales du TAVI : rôle des monocytes et de l'hématopoïèse clonale de signification indéterminée

Lassalle, F. (2022) · theses.fr (ABES) · doi:10.70675/0ce33ecaze48az4a42za546z661d5b004bf5

Clonal hematopoiesis: a shared risk factor for cardiovascular diseases and tumors

Zha, L., & Cheng, X. C. (2024) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000029

AGING AND CLONAL HEMATOPOESIS

Богданов, А. Н., Волошин, С. В., Куневич, Е. О., & Mikhaleva, M. (2024) · Успехи геронтологии · doi:10.34922/ae.2024.37.3.013

Clonal haemopoiesis and venous thromboembolism risk

Steensma, D. P. (2024) · British Journal of Haematology · doi:10.1111/bjh.19893

Acquired Disorders of Platelet Function

Scharf, R. E. (2025) · Springer eBooks · doi:10.1007/978-3-031-96348-3_17

Aging changes the mechanism that underlies JAK2 modulation of neutrophil function

Feldmann, J. W., Kays, M., McGinnis, F., Herron, E., Sati, N., Woods, C., & Coulibaly, A. P. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf323

Clonal hematopoiesis of unknown potential and cardiovascular disease – literature review

Goranov, G., & Goranova‐Marinova, V. (2025) · Bulgarian Cardiology · doi:10.3897/bgcardio.31.e165714

Coronary artery disease and cancer: Shared risk factors, pathogenesis, and treatment effects

Charbel, N., Aramouni, K., Sater, S., & Kreidieh, F. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100702

Microenvironment and therapeutic modulation of myelofibrosis in an experimental mouse model.

Gobbo, F. (2024) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/11167

Investigation of the role of inflammation in myeloproliferative neoplasms

Hoover, B. (2021) · eScholarship (California Digital Library)

Influenza A virus infection activates TLR3-mediated necroptosis

Li, W., Huang, C., Zeng, Z., Li, X., Xu, J., Gong, T. Y., Zhang, H., Zhang, X., Wang, P., Hu, Y., et al. (2025) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000093

Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives

Liu, Z. Z., Xiang, Y., Xie, C., Yin, X., Zhang, M., & Chen, Z. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109613

Elevated neutrophil extracellular traps in patients with BCR::ABL1-negative myeloproliferative neoplasms: pathophysiological insight beyond thrombosis?

Morath, O., Rinke, J., Walter, A., Schilling, K., Crodel, C. C., Hochhaus, A., & Ernst, T. (2026) · Hämostaseologie · doi:10.1055/s-0045-1814525

Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera

Masárová, L., Qin, A., Yoon, C. H., Yacoub, A., Prchal, J. T., & Mascarenhas, J. O. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06735-5

Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F–mutated essential thrombocythemia: a case report

ASHIDA, Y., Ota, S., Ishidoya, N., Murai, Y., Amenomori, K., Hasui, K., Kawaguchi, S., Yamaguchi, S., Hiraga, H., Kamata, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1781998

Polycythemia Vera Revealed by Acute Myocardial Infarction: A Case Report

Quintal, J., Flores, R. M. D. N., Duarte, T., António, A. S., & Seixo, F. (2026) · Reports — Medical Cases Images and Videos · doi:10.3390/reports9010091

Pathophysiology of cardiovascular events in Bcr/Abl-negative myeloproliferative neoplasms

Poisson, J. (2018) · theses.fr (ABES) · doi:10.70675/d71df373z8cc7z41c1z9896zab996bc5b48e

Impact of JAK2V617F on Terminal Erythroid Differentiation and Red Blood Cell Electrophysiology in Polycythemia Vera

Buks, R. (2020) · theses.fr (ABES) · doi:10.70675/07946d02zf45fz4cd6zb794z072ba390bb83

Rôle des cellules endothéliales avec mutation JAK2V617F et des polynucléaires neutrophiles dans la physiopathologie de la thrombose des néoplasies myéloprolifératives

Guy, A. (2018) · theses.fr (ABES) · doi:10.70675/97652ce4z1e0fz4da1za17bz0a8639893023

Mechanism of Action of Interferon in the Treatment of JAK2V617F-Positive Myeloproliferative Neoplasm

Dagher, T. (2021) · theses.fr (ABES) · doi:10.70675/70385a66zf181z4e65z9833z84f2ea720612

Etude de l’hétérogénéité clonale de tumeurs de patients atteints du cancer colorectal métastatique par l’analyse de l’ADN circulant au cours de leur prise en charge thérapeutique

Pastor, B. (2022) · theses.fr (ABES) · doi:10.70675/cdf456c9zfec4z45dez8582z0329e7f9f584

Thrombose veineuse cérébrale et néoplasies myéloprolifératives : impact physiopathologique de la mutation JAK2V617F

Bourrienne, M. (2023) · theses.fr (ABES) · doi:10.70675/d0594ae8z342ez443az8ec7z19db6dbc94e6

Exploration et modulation de l'immunité entrainée au cours de l'athérosclérose expérimentale

Lavillegrand, J. (2022) · theses.fr (ABES) · doi:10.70675/57d04b05za207z47faz8466z03904c89430b

Clonal hematopoiesis and immunosenescence as a prognostic biomarker for oncological treatments in solid tumors

Baldini, C. (2024) · theses.fr (ABES) · doi:10.70675/bdae243bz3d0fz496bz8a91zd8830398a17c

Les NETs (Neutrophils Extracellular Traps) et les DNases au cours de la COVID-19

Garcia, G. (2024) · theses.fr (ABES) · doi:10.70675/966d76edz52a6z40c0z8f18z57c699067db5

Rôle des Hématopoïèses clonales de potentiel indéterminé (CHIP) dans la physiopathologie des maladies cardiovasculaires

Dufossée, M. (2024) · theses.fr (ABES) · doi:10.70675/53fdcbefz6660z46f0z9a48z1b9387e87c9d

Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know

Oren, O., Singh, A., Carraway, H. E., Laffin, L. J., & Nissen, S. E. (2026) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.93a.26003

Introduction to the Review Series. Clonal hematopoiesis review series – from biology to clinical management

Piric, A. A., & Schimmer, A. D. (2026) · Haematologica · doi:10.3324/haematol.2025.288295

Clonal hematopoiesis and thrombosis risk—what are research and clinical gaps?

Englisch, C., & Ay, C. (2026) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2026.106650

Multi-Compartment Transcriptomics Identifies a Persistent Inflammatory Program and a Network-Derived Diagnostic Signature in Polycythemia Vera

Alruwetei, A. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104580

Hematopoietic somatic mutations in atherosclerotic cardiovascular disease

Ramos-Neble, B. L., & Fuster, J. J. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120718

Positive and Negative Cardiovascular Effects of JAK Inhibitors in Inflammation

Zavoriti, A., & Miossec, P. (2026) · ACR Open Rheumatology · doi:10.1002/acr2.90074

Association Between Clonal Hematopoiesis and Cardiometabolic Disease

D’Mello, B., Sheth, N., Orchanian‐Cheff, A., Soave, D. M., Abelson, S., Woo, M., & Ke, C. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.04.005

Neutrophil extracellular traps in thrombosis of hematologic malignancies: Underlying mechanisms and therapeutic opportunities (Review)

Lv, K., Ma, Z., Chen, Q., Yang, S., Ma, J., Wang, C., & Yu, L. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5901

Filgotinib induces apoptosis in colorectal cancer cells by activating the p53 signaling pathway

Zhou, Y., Li, Z., Zhao, Y. Q., Li, C., & Ye, H. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12115-z

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis

Corrao, K. M. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.06.005

Dysregulated neutrophil extracellular trap formation is a novel driver of clonogenicity and therapeutic vulnerability in CMMLPreprint

Yadav, S., Brown, C. T., Cody, M. J., Heaton, W. L., de Araujo, C. V., Marchetti, M., Campbell, R. A., Pomicter, A. D., Williams, J., Yost, C. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.28.741351

Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)

Xie, Z., Sekar, A., Paolo, G., Shaji, K., & Sameer, A. P. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.102615

JAK2 V617F Clonal Dynamics from Clonal Hematopoiesis to Myeloproliferative Neoplasms: A Systems Biology Review of Digital PCR-Based Molecular Monitoring

Ivanov, H. Y., Sotkova, I. G., & Goranova‐Marinova, V. (2026) · Applied Sciences · doi:10.3390/app16167940

Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities

kaikavoosnejad, F., Keyhani, A., Moosavi, S. S., Verdi, M., Yazdani, M. S., Asl, K. D., Mazloumi, Z., Mirzaei, H., Rafat, A., & Nejati, R. (2026) · Cancers · doi:10.3390/cancers18162718

High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome

Balla, E., Vorobcsuk, A., Kovacs, E., Kajtár, B., Herczeg, J., Korom, V. G., Eva, K., Peter, R., Barbara, S., Lacza, Á., et al. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70311

Visualizing and Targeting Tumor-Associated Neutrophils: Advanced Imaging, Therapeutic Reprogramming, and Cell-Based Delivery for Precision Oncology

Liu, A., Chen, D., Huang, Y., Wang, C., Zhu, C., Hu, J., Zhan, L., Lai, Y., Yao, D., & Wang, D. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218805

Managing thrombotic risk in myeloproliferative disorders

Gurumurthy, G., Ho, M., Thachil, J. V., & Sriskandarajah, P. (2026) · Expert Review of Hematology · doi:10.1080/17474086.2026.2732981

Professor Di Haixia’s Experience in Treating Myeloproliferative Neoplasms from the Perspective of “Marrow-Blood-Collaterals”

黄, 裕. (2026) · Traditional Chinese Medicine · doi:10.12677/tcm.2026.159509

Immune-mediated thrombosis in myeloproliferative neoplasms: Pathogenic pathways and clinical relevance

Zhang, H., Xiong, H., Guo, X., Wang, X., Li, L., & Zhang, L. (2026) · Leukemia Research · doi:10.1016/j.leukres.2026.108323

Toward Individualized Atherosclerosis Therapy: Clinical Endotypes, Programmable Therapeutics, and Delivery Constraints

Peng, Y., Li, R., Li, H., Zhou, J., Liu, X., Valente, G., Melo, T. D. C., Chen, S., & 顾镭 (2026) · Medicine Bulletin · doi:10.1002/mdb2.70046

JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke Neurology

Kristiansen, M. H., Kjær, L., Skov, V., Larsen, M. K., Ellervik, C., Nielsen, C. H., Hasselbalch, H. C., & Wienecke, T. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050497

Characterization of Congestive Heart Failure Phenotype in a Murine Model of JAK2V617F-positive Myeloproliferative NeoplasmPreprint

Sun, X., Zheng, H., & Zhan, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.754163

CO ‐Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions

Hasselbalch, H. C., Larsen, M. K., Löffler, L., Andersen, C., Davidsen, I. D., Jensen, M. H., Bechlund, J., Kjær, L., Skov, V., Nielsen, H. B., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.72317

Immunopathological Mechanisms Linking Atherosclerosis and Ischemic Stroke: From Microenvironmental Vulnerability to Precision Therapeutics

Liu, W., Zou, Q., Liu, W., & Huang, Z. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100164

Clonal Hematopoiesis of Indeterminate Potential and Heart Failure: Mechanisms, Risk Stratification, and Therapeutic Implications

Park, J. (2026) · International Journal of Heart Failure · doi:10.36628/ijhf.2026.0072

Cytoreductive therapy reduces JAK2 V617F + blood velocity and adhesion to activated endothelium

DaSilva, A., Islam, T. U., Menon, S., Nguyen, J., Krenik, P., Ruan, C., Luo, X., Wood, D. K., & Beckman, J. D. (2026) · British Journal of Haematology · doi:10.1111/bjh.70906

Inflammation and thrombosis: from pathophysiology to future treatments

Santagata, D., Giovenali, L., Guerrieri, E., Falsetti, L., Squizzato, A., & Moroncini, G. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04574-w

A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report

Zhu, X., Long, Y., Zhong, L., Wu, X., Xu, L., & Wu, J. (2026) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2026.083

Neutrophils prothrombotic characteristics during myeloproliferative neoplasms

Wolff, L., Guy, A., Gourdou‐Latyszenok, V., Favre, S., Colomer, S., Renault, M., Couffinhal, T., & James, C. (2020) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/j.acvdsp.2020.03.015 · Cited by 6

Thrombosis in Myeloproliferative Neoplasms Is Linked to Increased Neutrophil Extracellular Trap (NET) Formation

Wolach, O., Sellar, R. S., Martinod, K., McConkey, M. E., Silver, A. J., Chappell, R., Stone, R. M., Wadleigh, M., Steensma, D. P., DeAngelo, D. J., et al. (2016) · Blood · doi:10.1182/blood.v128.22.633.633 · Cited by 3

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms

Guy, A., Garcia, G., Gourdou‐Latyszenok, V., Wolff-Trombini, L., Josserand, L., Kimmerlin, Q., Favre, S., Kilani, B., Marty, C., Boulaftali, Y., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.08.028 · Cited by 48

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Cuenca‐Zamora, E. J., García-Gisbert, N., Reyes‐García, A. M. D. L., Aroca, C., Martínez-Montesinos, L., Andrade, M., Águila, S., Guijarro-Carrillo, P. J., Cifuentes‐Riquelme, R., Gónzález‐Conejero, R., et al. (2020) · Blood · doi:10.1182/blood-2020-139368 · Cited by 3

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events

Schmidt, S. U., Daniliants, D., Hiller, E., Gunsilius, E., Wolf, D. G. F., & Feistritzer, C. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004061 · Cited by 21